Published in Oncol Lett on September 25, 2017
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol (2013) 6.12
Inflammation and cancer: how hot is the link? Biochem Pharmacol (2006) 5.17
Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol (2013) 3.95
Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy (2001) 3.93
The codependence of angiogenesis and chronic inflammation. FASEB J (1997) 3.02
Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis (2005) 2.98
Inflammation: gearing the journey to cancer. Mutat Res (2008) 2.89
Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med (2011) 2.77
Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis (2003) 2.59
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene (2001) 2.22
Outdoor particulate matter exposure and lung cancer: a systematic review and meta-analysis. Environ Health Perspect (2014) 2.20
IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep (2009) 2.14
Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature (2015) 1.94
National cancer incidence and mortality in China, 2012. Chin J Cancer Res (2016) 1.90
A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br J Cancer (2013) 1.77
Circulating inflammation markers and prospective risk for lung cancer. J Natl Cancer Inst (2013) 1.59
Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC). Clin Lung Cancer (2011) 1.41
Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms. Ann Thorac Surg (2009) 1.40
Multifaceted link between cancer and inflammation. Biosci Rep (2012) 1.39
Occupational and environmental causes of lung cancer. Clin Chest Med (2012) 1.15
The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol (2014) 1.11
Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol (2014) 1.09
Cancer and inflammation: a complex relationship. Cancer Lett (2008) 1.04
Association of epidermal growth factor receptor activating mutations with low ERCC1 gene expression in non-small cell lung cancer. J Thorac Oncol (2010) 1.02
A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. Onco Targets Ther (2015) 1.00
Gastrin, inflammation, and carcinogenesis. Curr Opin Endocrinol Diabetes Obes (2010) 0.90
Lung cancer burden has increased during the last 40 years in Hebei Province, China. Thorac Cancer (2016) 0.89
Increased Neutrophil-Lymphocyte Ratio Is a Poor Prognostic Factor in Patients with Esophageal Cancer in a High Incidence Area in China. Arch Med Res (2015) 0.87
Analysis of the intricate relationship between chronic inflammation and cancer. Biochem J (2015) 0.86
Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC). PLoS One (2016) 0.85
Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer. PLoS One (2016) 0.80
Molecular characterization of STAT signaling in inflammation and tumorigenesis. Methods Mol Biol (2009) 0.79
Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma. PLoS One (2015) 0.79
Epidermal growth factor receptor gene mutation status and its association with clinical characteristics and tumor markers in non-small-cell lung cancer patients in Northwest China. Mol Clin Oncol (2015) 0.78
The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review. Clin Genitourin Cancer (2016) 0.78
Biomarkers of risk to develop lung cancer in the new screening era. Ann Transl Med (2016) 0.78
Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy. Biomed Res Int (2016) 0.78
Neutrophil-Lymphocyte Ratio Predicts Survival in Terminal Cancer Patients. J Palliat Med (2016) 0.77
Platelet activation and fibrinolysis in large bowel cancer. Oncology (1995) 0.77
Retraction Note to: Identification of featured biomarkers in different types of lung cancer with DNA microarray. Mol Biol Rep (2015) 0.76
Retraction: HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature (2015) 0.76
Detection of cancer embryo antigen and endothelin-1 in exhaled breath condensate: A novel approach to investigate non-small cell lung cancer. Mol Clin Oncol (2016) 0.76
Prognostic role of liver X receptor-alpha in resected stage II and III non-small-cell lung cancer. Clin Respir J (2016) 0.76
Association of the Neutrophil-to-Lymphocyte Ratio with Lung Function and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease. PLoS One (2016) 0.76
31 years of lung cancer in the canton of Zurich, Switzerland: incidence trends by sex, histology and laterality. Swiss Med Wkly (2016) 0.76
The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? Ther Adv Med Oncol (2016) 0.75